Numerous studies have shown that PCSK9 plays a significant role in cardiovascular disease, partially independent of its effect on lipid metabolism, and modern lipid-lowering therapy can help reduce cardiovascular risk in adults. Here, PCSK9 is linked to cardiovascular disorder.